High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement.
Robak
Tadeusz
T
Kordek
Radzisław
R
Urbanska-Rys
Halina
H
Robak
Pawel
P
Bartkowiak
Jacek
J
Bednarek
Andrzej
A
Chudobinski
Cezary
C
Chojnowski
Krzysztof
K
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001855:Bone Marrow Diseases; D017338:Cladribine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008171:Lung Diseases; D008230:Lymphomatoid Granulomatosis / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D017338:Cladribine; D000069283:Rituximab; D003520:Cyclophosphamide